Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

作者: Abir Salwa Ali , Malin Grönberg , Birgitte Federspiel , Jean-Yves Scoazec , Geir Olav Hjortland

DOI: 10.1371/JOURNAL.PONE.0187667

关键词: CancerP53 proteinInternal medicineNeuroendocrine carcinomaNeuroendocrine CarcinomasOncologyChemotherapyMedicinePancreas

摘要: Background Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) are aggressive, rapidly proliferating tumors. Therapeutic response to current chemotherapy regimens is usually short lasting. ...

参考文章(23)
Halfdan Sorbye, Jonathan Strosberg, Eric Baudin, David S. Klimstra, James C. Yao, Gastroenteropancreatic high-grade neuroendocrine carcinoma. Cancer. ,vol. 120, pp. 2814- 2823 ,(2014) , 10.1002/CNCR.28721
Koji Ando, Eiji Oki, Hiroshi Saeki, Zhao Yan, Yasuo Tsuda, Gen Hidaka, Yuta Kasagi, Hajime Otsu, Hiroyuki Kawano, Hiroyuki Kitao, Masaru Morita, Yoshihiko Maehara, Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancer Cancer Medicine. ,vol. 4, pp. 75- 83 ,(2015) , 10.1002/CAM4.346
Anna Fen-Yau Li, Shyh-Haw Tsay, Wen-Yih Liang, Wing-Yin Li, Jeou-Yuan Chen, Clinical Significance of p16INK4A and p53 Overexpression in Endocrine Tumors of the Gastrointestinal Tract American Journal of Clinical Pathology. ,vol. 126, pp. 856- 865 ,(2006) , 10.1309/5X6WBYJ3U94EEKNN
C A Jones, S Sexton, C M LeVea, S M Caraker, G Hajduczok, K W Gross, S T Glenn, Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma. Oncogene. ,vol. 33, pp. 5706- 5715 ,(2014) , 10.1038/ONC.2013.514
N. Rivlin, R. Brosh, M. Oren, V. Rotter, Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis Genes & Cancer. ,vol. 2, pp. 466- 474 ,(2011) , 10.1177/1947601911408889
Stefano La Rosa, Alessandro Marando, Fausto Sessa, Carlo Capella, Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update Cancers. ,vol. 4, pp. 11- 30 ,(2012) , 10.3390/CANCERS4010011
Anna Yemelyanova, Russell Vang, Malti Kshirsagar, Dan Lu, Morgan A Marks, Ie Ming Shih, Robert J Kurman, Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis Modern Pathology. ,vol. 24, pp. 1248- 1253 ,(2011) , 10.1038/MODPATHOL.2011.85
Lesley Lomo, Marisa R Nucci, Kenneth R Lee, Ming-Chieh Lin, Michelle S Hirsch, Christopher P Crum, George L Mutter, Histologic and immunohistochemical decision-making in endometrial adenocarcinoma Modern Pathology. ,vol. 21, pp. 937- 942 ,(2008) , 10.1038/MODPATHOL.2008.97
N Akeno, A L Miller, X Ma, K A Wikenheiser-Brokamp, p53 suppresses carcinoma progression by inhibiting mTOR pathway activation Oncogene. ,vol. 34, pp. 589- 599 ,(2015) , 10.1038/ONC.2013.589
Yan-Song Bian, Maria-Chiara Osterheld, Fred T Bosman, Jean Benhattar, Charlotte Fontolliet, p53 Gene Mutation and Protein Accumulation during Neoplastic Progression in Barrett's Esophagus Modern Pathology. ,vol. 14, pp. 397- 403 ,(2001) , 10.1038/MODPATHOL.3880324